Tags |
|
|
Links |
|
|
Main Subject - Choosing A Domain Name
--About Domain Names--
Choosing a domain name for your
Choosing a domain name for your
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
web site is a major step for any individual or organiz
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ation. You need domain names that are sticky, short, me
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ningful, easy to remember and at the roll of your tongu
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
e!
It is very easy to choose a domain name but difficu
It is very easy to choose a domain name but difficu
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
t to find a good name, simply because of the fact that
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
most of the good domain names are taken up by organisat
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ons. These domain name organisations take up hundreds o
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
f thousands of domain names and treat them as investmen
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
s. It is not as easy to choose a good domain name. Some
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
times, even web professionals spend hours at their comp
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
uters to find good domain names!
Domain name registrat
Domain name registrat
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
ons are cheap to maintain and subscriptions typically l
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
ast a year. The subscriptions are renewable and paid to
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
registrars by the design companies.
The most common do
The most common do
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
main names end with .com, .net, etc. Country specific d
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
main names will end with com.au, co.uk, .co.jp, etc. Fo
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
r organisations, domain names will end with .org or be
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
ountry specific- .org.au, .org.uk, etc.
Not sure about
Not sure about
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
domain names and web sites? Seek web professional help
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/59573/mainsubjects-Choosing-A-Domain-Name.html">Choosing A Domain Name</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/59573/mainsubjects-Choosing-A-Domain-Name.html]Choosing A Domain Name[/url]
Related Articles:
How To Build A Home Internet Business And Keep Your Finances Under Control
Bookmark it:
|